Please assess the completion status of the following clinical trial:

Trial Title: Measurement of D-Dimer Levels in Patients With Confirmed Deep Vein Thrombosis

Study Design Characteristics:
- Allocation: None
- Intervention Model: None
- Observational Model: CASE_ONLY
- Primary Purpose: None
- Time Perspective: PROSPECTIVE
- Masking: None
- Phase: None
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* The study population tested will be recruited from ambulatory outpatients (presenting at the emergency unit or outpatient clinic) suspected of having DVT.~* Patient is \< 80 years old.~* Patient presenting at least one of these symptoms indicative of proximal DVT: leg pain, tenderness (discomfort through palpation), leg swelling and /or edema,~* Patient has confirmed proximal DVT by imaging~* Low or moderate Wells score~* Patient provides written informed consent to participate in the sample collection~Exclusion Criteria:~* Patient presenting with a condition that may be associated with increased D-dimer levels, even in the absence of VTE, such as:~  1. Fibrinolytic therapy within the previous seven (7) days,~ 2. Bone fracture or surgery (with general anesthesia longer than thirty (30) minutes) within the previous one (1) month,~ 3. Deep hematoma diagnosed by imaging techniques within the previous one (1) month,~ 4. Disseminated malignancies and active cancer (active cancer defined as: cancer for which therapeutic or palliative treatment is either ongoing at the time of enrolment or has stopped less than six (6) months before enrolment),~ 5. Sepsis, severe infections, pneumonia within the previous 1 month,~ 6. Known liver cirrhosis,~ 7. Pregnancy or post-partum within the previous 1 month,~ 8. Atherosclerotic vascular disease thrombosis within the previous 1month (e.g. myocardial infarction, stroke, coronary syndrome, peripheral artery disease stage III or IV),~ 9. Sickle cell disease,~* Patients presenting with a suspect thrombotic event related to catheter implantation~* Ongoing therapeutic anticoagulants (curative and preventive treatment) starting twenty four (24) hours or more before the blood drawing for D-dimer testing

- Gender: ALL
- Minimum Age: None
- Maximum Age: 80 Years
- Healthy Volunteers: f

Study Arms:
- Deep Venous Thrombosis (DVT) (Type: None): DVT diagnosed by imaging technique with a low or moderate Wells score

Based on this trial design, predict the completion outcome and termination type (if applicable).